Showing results (1-10 of 25) with videos related to
Sort By:
Pageof 3
Journal of Clinical Pharmacology|August 11, 2023
Correlations of PCSK9 and LDLR Gene Polymorphisms and Serum PCSK9 Levels With Atherosclerosis and Lipid Metabolism in Patients on Maintenance HemodialysisJun Cui, Yuxiang Qiu, Ningsu Kang, et al.Medicine|June 30, 2025
Comparison of drug-coated balloon and conventional balloon in autologous arteriovenous fistula stenosisNingsu Kang, Yuxiang Qiu, Xi Wang, et al.Optics Express|July 16, 2021
Adaptive Bayesian algorithm for achieving a desired magneto-sensitive transitionChengyin Han, Jiahao Huang, Xunda Jiang, et al.Peerj|October 4, 2023
Loss of Farnesoid X receptor (FXR) accelerates dysregulated glucose and renal injury in db/db miceYuxiang Qiu, Ningsu Kang, Xi Wang, et al.Progress in Neuro-Psychopharmacology & Biological Psychiatry|March 28, 2026
Regulation of short-term declarative memory by selective activation of the locus coeruleus-retrosplenial cortex dopaminergic pathway and its pathological alterations in Parkinson's diseaseYalong Yan, Linyun Gao, Xiyu Qiang, et al.Frontiers in Molecular Neuroscience|August 15, 2024
High expression of COPZ2 is associated with poor prognosis and cancer progression in gliomaZhi Geng, Chunyan Mu, Yuxiang Qiu, et al.Micromachines|May 27, 2026
A Physics-Data Hybrid Framework Using Uncalibrated Consumer CMOS Vision: Pilot Study on Monocular Automatic TUG Assessment Towards Early Parkinson's Disease Risk ScreeningYuxiang Qiu, Xiaodong Sun, Fan Yang, et al.Applied Optics|June 18, 2021
Laser frequency stabilization via bichromatic Doppler-free spectroscopy of an <sup>87</sup>Rb D<sub>1</sub> lineMinhua Zhao, Xunda Jiang, Ruihuan Fang, et al.Frontiers in Genetics|April 10, 2025
Identification of mitochondrial permeability transition-related lncRNAs as quantitative biomarkers for the prognosis and therapy of breast cancerZhongshu Lin, Xinlu Wang, Guanxiang Hua, et al.Biochimica Et Biophysica Acta. Molecular Basis of Disease|May 3, 2023
TCF12 regulates exosome release from epirubicin-treated CAFs to promote ER+ breast cancer cell chemoresistanceYuxiang Qiu, Xing Wang, Yan Sun, et al.Pageof 3